Genzyme: FDA panel verdict presents setback to leukemia drug
Genzyme's plan to expand Clolar's label to include adult myeloid leukemia (AML) has been held up after an FDA advisory committee voted against its approval due to a lack of data. This news comes as a setback to Genzyme, and unless Clolar can show the desired efficacy among Genzyme's target patient population of elderly AML patients, further uptake of the drug in the clinical setting is unlikely.
Tuberculosis is a chronic infection caused by the bacteria Mycobacterium tuberculosis (and occasionally other variants of Mycobacterium). It usually involves the lungs, but other organs of the body can also be involved. Tuberculosis (TB) is a disease caused by bacteria called Mycobacterium tuberculosis. The bacteria usually attack the lungs.
The whole 11 pages article is available for download at Downloads section of Farmavita.Net.
The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipeline analysis
This report provides comprehensive coverage of every class of drugs across major cardiovascular indications and profiles the underlying trends and factors driving the market. Detailed insights into recent key events and future market leaders are also provided, in addition to epidemiological analysis and forecasts for major products over the 2007-13 period.
AstraZeneca and Boehringer Ingelheim steal limelight at European Society of Cardiology meeting
Well crafted, positive results for AstraZeneca's Brilinta and an unexpected coup for Boehringer Ingelheim's Pradaxa dominated the headlines following this year's European Society of Cardiology's Annual Meeting in Barcelona. Both announcements have a number of important implications for the wider cardiology market, from both therapeutic and commercial perspectives.
Open Innovation
New R&D Paradigm for Pharmaceutical Industry
Over the next
decade, the life sciences industries will be faced with sweeping demographic
shifts, energy and environment threats, increasing globalization, mounting
health care costs, the rise of emerging markets, and accelerating convergence
between industry sectors. The life sciences industries are clearly poised for a
period of massive shifts, and the most successful players in 2015 will be those
whose strategies not only reflect these trends, but also adapt to them and take
advantage of them.
To do so,
life sciences companies must first clearly understand the forces that are
changing the industries, and the issues that they will need to overcome in
order to be successful in 2015.
Antihypertensive drugs are medicines that help lower blood pressure in people whose blood pressure is too high. Blood pressure is a measurement of the force with which blood moves through the body's system of blood vessels.
The whole 12 pages article is available for download at Downloads section of Farmavita.Net.
Migraine headaches result from a combination of blood vessel enlargement and the release of chemicals from nerve fibers that coil around these blood vessels. During the headache, an artery enlarges that is located on the outside of the skull just under the skin of the temple (temporal artery).
The whole 15 pages article is available for download at Downloads section of Farmavita.Net.
RECENT ADVANCEMENTS IN MICROWAVE TECHNOLOGY IN PHARMACEUTICAL INDUSTRY
Microwave is apparently heading for exhibiting good potential in the field of Pharmaceutical industry. The write up attempts to throw light on what is microwave, how is it generated and what importance may it have.
The whole 7 pages article is available for download at Downloads section of Farmavita.Net.
FORMULATION TECHNOLOGIES FOR DRUG DELIVERY TO THE UPPER SMALL INTESTINAL WINDOW
Oral bioavailability of certain drugs can be limited by the residence time of pharmaceutical formulation in the upper gastrointestinal tract. Gastric emptying plays an important role in the dynamics of drug absorption and can lead to variable and unpredictable availability. And it becomes more critical for drugs which are exclusively absorbed in the upper small intestine or in a limited segment of the intestine. To overcome this restriction and to increase the bioavailability of these drugs, controlled drug delivery systems with a prolonged residence time in the stomach can be used. Approaches to achieving prolonged residence times of the devices in the upper part of the gastrointestinal tract include the use of bioadhesive, size increasing, and floating drug delivery systems.
The whole 16 pages article is available for download at Downloads section of Farmavita.Net.
ACANTHUS ILICIFOLIUS LINN. - TRADITIONAL IMPORTANCE OF LESS KNOWN MEDICINAL PLANTS
Herbs are vital source of drugs from the ancient time holding the scenario of the Indian system of medicine. Acanthus ilicifolius Linn. (Acanthaceae) is relatively lesser-known, yet important medicinal plant of Herbal Materia Medica. The plant is used in traditional systems of medicine, including Traditional Indian Medicine.
The whole 5 pages article is available for download at Downloads section of Farmavita.Net
StayinFront, Inc signs two year global partnership agreement with eyeforpharma
July 21, 2009, London
eyeforpharma has signed a two year partnership agreement with StayinFront Inc. a global provider of enterprise-wide life sciences CRM and SFA solutions. StayinFront will be partnering with eyeforpharma worldwide on conferences, webinars, seminars and newsletters on topics ranging from CRM and Sales Force Effectiveness to eMarketing, Electronic Territory Mapping System and Key Account Management. There will also be a major online and electronic presence supporting this strategic relationship. Paul Simms the Managing Director of eyeforpharma stated that "eyeforpharma has worked closely with StayinFront for a number of years. This partnership is a natural progression of our close global relationship. I look forward to collaborating and reaching our mutual goals and objectives."
Martin Hensen, head of e-strategies, UCB Germany: Making e-marketing more than just an add-on
July 31, 2009, London
With the vast majority of our marketing efforts focused squarely on the sales force, e-marketing is still an "add on," says Martin Hensen, head of e-strategies, UCB Germany. But successful e-CRM strategies are the basic starting point for all e-activities, he told eyeforpharma.
Pharmaceutical Patent Intelligence firm GenericsWeb today announced that it had achieved in excess of 30% growth in revenue over the past financial year ending June 30th 2009, despite facing tough economic circumstances due to the global financial meltdown.
Global Pharmaceutical companies based in developed countries are increasingly turning to developing countries and emerging economies around the world for conducting clinical trials. Reduced costs combined with easy availability of patients with varied diseases makes developing countries favourite destinations for clinical research outsourcing.
The whole 9 pages article is available for download at Downloads section of Farmavita.Net
A COMPREHENSIVE REVIEW ON SUSTAIN EXTENDED RELEASE MULTIUNIT PARTICULATE ORAL DRUG DELIVERY SYSTEMS
The term ‘Sustained Release' is known to have existed in the medical and pharmaceutical literature for many decades. Sustain release has been constantly used to retard the release of therapeutic agent such that its appearance in the circulation is delayed and/or prolonged and its plasma profile is sustained in duration. The onset of its pharmacological action is often delayed and duration of therapeutic action is sustained.
The whole 31 pages article is available for download at Downloads section of Farmavita.Net
RECENT TRENDS IN SUSTAINED RELEASE MATRIX DRUG DELIVERY SYSTEM-AN OVERVIEW
Oral drug delivery has been known for decades as the most widely utilized route of administration among all the routes that have been employed for the systemic delivery of drug via various pharmaceutical products of different dosage forms. The reasons that the oral route achieved such popularity may be in part attributed to its ease of administration belief that by oral administration of the drug is well absorbed.
The whole 21 pages article is available for download at Downloads section of Farmavita.Net
THE ROLE OF INTELLECTUAL PROPERTY RIGHTS IN TRADITIONAL KNOWLEDGE: AN OVERVIEW
Intellectual properties (IP) are legal property rights over creations of the mind, both artistic and commercial, and the corresponding fields of law. Under intellectual property law, owners are granted certain exclusive rights to a variety of intangible assets, such as musical, literary, and artistic works; ideas, discoveries and inventions; and words, phrases, symbols, and designs.
The whole 4 pages article is available for download at Downloads section of Farmavita.Net
PATHOPHYSIOLOGY, DRUG OFFERED AND CURRENT APPROACHES OF TRADITIONAL SYSTEM OF MEDICINE IN THE TREATMENT OF PEPTIC ULCER
Peptic ulcer generally occurs when there is an imbalance between aggressive gastric factors (acid, pepsin, Helicobacter pylori, refluxed bile salts) and defensive mucosal factors (gastric mucosal barrier, bicarbonate secretion, rapid cell turnover, high blood flow). The treatment of peptic ulcer is directed against reduction of aggressive factors or enhancement of mucosal defense of stomach and duodenum with cytoprotective agents.
The whole 19 pages article is available for download at Downloads section of Farmavita.Net
The search function “Peple Finder” enables you to serch the list of registered users and to find contacts that are relevant to
you. This powersearch will look into diffrent fieals of member profile. For instance, you can serarch for specific name, company, city, country or interest related to other members.
You can connect to other users. On the profile page click on tab Connections>Request Connection . You should keep quality in
mind choosing contacts you want to add.
Farmavita.Net Journal 
Over the next
decade, the life sciences industries will be faced with sweeping demographic
shifts, energy and environment threats, increasing globalization, mounting
health care costs, the rise of emerging markets, and accelerating convergence
between industry sectors. The life sciences industries are clearly poised for a
period of massive shifts, and the most successful players in 2015 will be those
whose strategies not only reflect these trends, but also adapt to them and take
advantage of them.
GenericsWeb Holds Course through Economic Turmoil
